Base
N2483842013-12-26New YorkClassification

The tariff classification of Carbidopa/Levodopa Tablets, imported in dosage form, from India

U.S. Customs and Border Protection · CROSS Database · 1 HTS code referenced

Cross-Source Intelligence

Data compiled from CBP CROSS Rulings, Census Bureau Trade Data · As of 2026-04-29 · Updates monthly

Summary

The tariff classification of Carbidopa/Levodopa Tablets, imported in dosage form, from India

Ruling Text

N248384 December 26, 2013 CLA-2-30:OT:RR:E:NC:2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9140 Mr. Donal O. Sullivan BluePoint Laboratories Eastgate Business Park Eastgate Road, Building 1 Little Island, Cork Ireland RE: The tariff classification of Carbidopa/Levodopa Tablets, imported in dosage form, from India Dear Mr. Sullivan: In your letter dated November 29, 2013, you requested a tariff classification ruling. The subject product, Carbidopa/Levodopa Tablets, is a medicinal preparation, in tablet form, containing Carbidopa and Levodopa as active ingredients. Carbidopa/Levodopa Tablets are indicated for the treatment of Parkinson’s disease. The applicable subheading for Carbidopa/Levodopa Tablets in dosage form will be 3004.90.9140, which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at (646) 733-3033. Sincerely, Gwenn Klein Kirschner Acting Director National Commodity Specialist Division